StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AMARC.BK$3.36+0.60%
Fair $3.36+0.0%

AMARC.BK

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited

Technology / Scientific & Technical InstrumentsThailand

$3.36

+0.02 (+0.60%)

Fairly Valued+0.0%Fair Value $3.36Fund rank 33/100 · Data gapFallback financials|
SA 70/B
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $56.0M · quality 60.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 43/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

70/100

B

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · AMARC.BKLocal privado en este navegador · Asia Medical and Agricultural Laboratory and Research Center Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.4B

P/E

8.8x

↓

EV/EBITDA

6.9x

↓

ROE

26.3%

↑

Gross Margin

54.0%

↑

Debt/Equity

0.03

↓
52-Week Range$3
$2$6

TradingView lightweight chart

AMARC.BK price, volumen y niveles de valoración

Último $3.360Periodo -11.6%
Fair value: $3.360

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+23.1%

FCF CAGR

+70.4%

FCF margin

32.1%

FCF / Net income

0.99x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $491.0M · net income $158.6M · FCF $157.5M

2022-FY → 2025-FY

Gross margin

54.0%+14.1% pts

Operating margin

32.2%+23.1% pts

Net margin

32.3%+26.8% pts

FCF margin

32.1%+20.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$491.0M$491.0M$344.8M$289.2M$263.2M
Net Income$158.6M$158.6M$39.9M$9.6M$14.5M
EBITDA$199.8M$199.8M$81.7M$52.5M$57.6M
EPS0.380.380.100.020.04
Gross Margin54.0%54.0%40.4%37.5%39.9%
Operating Margin32.2%32.2%11.9%5.5%9.2%
Net Margin32.3%32.3%11.6%3.3%5.5%
Balance Sheet
Debt/Equity0.030.030.070.130.17
Current Ratio5.095.09———
Cash Flow
Free Cash Flow$157.5M$157.5M$56.0M$-13.5M$31.8M
Returns
ROE26.3%26.3%7.7%1.9%2.6%
Valuation
P/E8.848.8413.4771.0067.00
EV/EBITDA6.946.946.6812.0416.04
P/B2.342.341.031.161.60
Growth & Yield
Revenue Growth42.4%42.4%19.2%9.9%—
EPS Growth297.9%297.9%375.0%-50.0%—
Dividend Yield7.9%7.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-7.6%

fácil

EPS terminal req.

$0.30

Spread vs growth

305.5%

5Y implied EPS CAGR

-0.9%

fácil

EPS terminal req.

$0.36

Spread vs growth

298.8%

10Y implied EPS CAGR

4.4%

fácil

EPS terminal req.

$0.58

Spread vs growth

293.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +87.6%

Total return

+87.6%

Start / end P/E

19.7x → 8.9x

EPS bridge

0.10 → 0.38

Residual

-163.4%

EPS growth+297.9%
Multiple rerating-54.8%
Dividend+7.9%
Residual / FX / buybacks / cross-term-163.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.